Home / World / Scott Gottlieb is expected to have little impact on US COVID patients.

Scott Gottlieb is expected to have little impact on US COVID patients.

The recently announced Scott Scott Lee of the Biden Administration for travelers from India is unlikely to play a role in limiting people infected with the new coronavirus in the United States. Scott Lee told CNBC on Friday.

“It will have an impact or maybe it will have little impact on the margins in terms of reducing the introduction. It will not have a big impact on our way now,” the former Food and Drug Administration said in “Closing.” Bell “” It may do more harm to India than any good for us. ”


Gottlieb, who sits on the board of Pfizer, the maker of the COVID vaccine, said he thinks the White House’s main reason for restricting travel from India is concern about the strain of COVID-19 known as B.1.617. It was first found in the country and believed to be highly contagious.

“But that variable is still here, and the best way to reduce that variable’s risk is to get more Americans to get vaccinated,” said Gottlieb, who led the FDA in the Trump administration in 2017. To 2019 said “that would be so The best backstop with variable spread is not limited to travel at this point. “

The White House press secretary Jen Psaki announced the travel restrictions, which will take effect Tuesday. India has experienced a high epidemic of COVID in recent weeks, straining its healthcare system as the number of daily deaths soared to record highs.

The travel directive is expected to apply to non-US citizens or new permanent residents in India, according to a person familiar with the matter. That means the restrictions will take a pattern similar to those that apply to many trips to the United States from China, Brazil and the European Union, effectively limiting most visitors from India to the United States.

“There is some research showing that when you apply travel restrictions and most of the studies that have been done look at it in the context of the influenza pandemic, you can slow down the introduction of the virus into new regions.” Yes, which you will slow down Recommending and possibly helping reduce the peak of the epidemic that other countries are going to suffer, “Gottlieb said.

If the United States were to place “non-leaking” travel restrictions earlier in the outbreak, Gottlieb said, it would likely take longer for the coronavirus to enter the country and limit the severity of the outbreak.

“But at this point, we have enough viruses here in the United States that we are not preventing the adoption of the Indian virus,” he said.

The White House did not immediately respond to CNBC’s request for comment on Gottlieb’s remarks.

Coronavirus cases in the United States have continued to decline as more Americans are vaccinated against COVID. As of Friday, data from the Centers for Disease Control and Prevention showed that more than 100 million Americans were fully vaccinated.

The new vaccinations, however, are slowing down each day, and states are trying to attract Americans who are not particularly keen on getting COVID.

“I think we can continue to do it,” Gottlieb said, adding that the average daily drop in shots was going to be a huge hit. “It doesn’t mean we’re not doing a good job,” he added. “I think it is inevitable that it will start to slow down as you enter reduced demand.”

“Things like vaccinated buses that they drive into communities and people can show up and get vaccinated on-site without waiting. That’s how we get people to get vaccinated.” “Getting vaccines through the workplace will also help.”

Disclosure: Scott Gottlieb is a CNBC contributor and board member of Pfizer, Tempus genetic testing startup Tempus, healthcare technology company Aetion Inc. and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings and Royal Caribbean’s “Healthy Sail Panel”.

Source link